🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Transplant Rejection

Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection NCT05084768n/a1 site📍 Loma Linda Loma Linda University · Tests: Donor-derived cell-free DNA Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity NCT07134491n/a2 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Piece of kidney removal, Stool collection, Blood collection Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation NCT06794970n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna A Study of AI in Cardiac Transplant in Echocardiographic Analysis (ORACLE) NCT06178744n/a1 site📍 Rochester Mayo Clinic A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications NCT04877288Phase 338 sites📍 Birmingham📍 Los Angeles📍 Washington D.C. Bristol-Myers Squibb · Tests: Belatacept, Tacrolimus, Cyclosporine A, Mycophenolate Mofetil, Enteric Coated Mycophenolate Sodium IMR-Heart Trasplant Study NCT06656065n/a2 sites📍 L'Hospitalet de Llobregat📍 Zaragoza Hospital Miguel Servet Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring NCT07060716n/a10 sites📍 Los Angeles📍 Jacksonville📍 Tampa Insight Molecular Diagnostics · Tests: donor-derived cell-free DNA test Endothelial Glycocalyx Damage in Brain Death Organ Donors NCT05609123n/a1 site📍 Hradec Králové University Hospital Hradec Kralove · Tests: Endothelial glycocalyx damage assessment Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies NCT05385432Phase 31 site📍 Tours University Hospital, Tours · Tests: Rabbit Anti thymocyte globulin (rATG), Basiliximab Genome Transplant Dynamics NCT02423070n/a7 sites📍 Phoenix📍 Washington D.C.📍 Baltimore National Heart, Lung, and Blood Institute (NHLBI) Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients NCT05793203n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS A Clinical Study of Association Between Postoperative Dyslipidemia and Organ Rejection in Transplant Patients NCT05994274n/a1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation NCT07412470Phase 2, Phase 373 sites📍 San Francisco📍 Atlanta📍 Hines Sanofi · Tests: Frexalimab, Frexalimab, Tacrolimus, rabbit anti-thymocyte globulin, mycophenolate mofetil Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection NCT07663669n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch NCT06493526Phase 41 site📍 Edegem University Hospital, Antwerp · Tests: Withdrawal of calcineurin-inhibitor, continue on concentration-controlled mycophenolate mofetil and corticosteroids. Tissue Analysis of Liver Grafts as a Predictor of Transplant Outcome. NCT06717542NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: histochemical and immunohistochemical analysis, RT-PCR Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant NCT05027906Phase 1, Phase 29 sites📍 Cincinnati📍 Camperdown📍 Adelaide Eledon Pharmaceuticals · Tests: AT-1501 Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants NCT00106925n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Proteogenomic Monitoring and Assessment of Liver Transplant Recipients NCT01644903n/a1 site📍 Chicago Northwestern University A Prospective Randomized Trial of ECP in Subclinical AMR NCT06112951NA7 sites📍 Vienna📍 Leuven📍 Zagreb Medical University of Vienna · Tests: Extracorporeal Photopheresis TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation NCT06829719NA4 sites📍 Bordeaux (France)📍 Lyon📍 Strasbourg (france) Hospices Civils de Lyon · Tests: TTV DNAemia, EQ-5D-5L questionnaire, Biological tests Empagliflozin Treatment in Kidney Transplant Recipients NCT06013865Phase 45 sites📍 Hines📍 Iowa City📍 Omaha VA Office of Research and Development · Tests: Empagliflozin Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients NCT06910527n/a1 site📍 Rouen Poulet Geoffroy Transcriptomics as an Aid in the Histological Diagnosis of Acute Rejection After Liver Transplantation NCT06734013NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Molecular diagnostic Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children NCT04924491Phase 1, Phase 21 site📍 Madrid Rafael Correa-Rocha · Tests: Autologous thyTreg Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma NCT06254248Phase 210 sites📍 Clichy📍 Créteil📍 Lille Assistance Publique - Hôpitaux de Paris · Tests: Systemic therapy Immunological Mechanisms of Rejection in Uterine Transplantation NCT04615221NA1 site📍 Suresnes Hopital Foch · Tests: Specimens Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor NCT03707262Phase 1, Phase 21 site📍 Los Angeles Jeffrey Veale, MD · Tests: Donor CD34+ and CD3+ cells Immune Biomarkers for Predicting Complications After Liver Transplantation NCT07875595n/a3 sites📍 Pilar📍 Buenos Aires📍 Buenos Aires Hospital Italiano de Buenos Aires · Tests: Immune Biomarker Assessment Daratumumab for Late Antibody-Mediated Rejection NCT07081126NA1 site📍 Martin University Hospital, Martin · Tests: Daratumumab (Subcutaneously), control group
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy